 Preston Bratcher
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis Transmembrane Conductance Regulator | 14 | 2025 | 312 | 6.660 |
Why?
| | Aminophenols | 10 | 2025 | 144 | 3.750 |
Why?
| | Cystic Fibrosis | 16 | 2024 | 1053 | 3.370 |
Why?
| | Quinolones | 8 | 2025 | 126 | 3.100 |
Why?
| | Benzodioxoles | 7 | 2022 | 105 | 1.900 |
Why?
| | Indoles | 3 | 2022 | 384 | 1.320 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 3 | 2014 | 35 | 1.290 |
Why?
| | Streptococcus pneumoniae | 4 | 2010 | 159 | 1.180 |
Why?
| | Epithelial Cells | 7 | 2025 | 1063 | 1.100 |
Why?
| | Chloride Channel Agonists | 3 | 2021 | 77 | 0.970 |
Why?
| | Pyrrolidines | 2 | 2022 | 67 | 0.920 |
Why?
| | Cyclic AMP | 1 | 2025 | 237 | 0.880 |
Why?
| | Neutrophils | 6 | 2019 | 1207 | 0.750 |
Why?
| | Bacterial Capsules | 3 | 2010 | 28 | 0.740 |
Why?
| | Pyrazoles | 2 | 2022 | 404 | 0.740 |
Why?
| | Pyridines | 2 | 2022 | 478 | 0.720 |
Why?
| | Epithelial Sodium Channels | 1 | 2021 | 19 | 0.720 |
Why?
| | Quinolines | 1 | 2021 | 156 | 0.690 |
Why?
| | Chlorides | 1 | 2020 | 139 | 0.650 |
Why?
| | Tetraspanin 30 | 2 | 2018 | 10 | 0.640 |
Why?
| | Receptors, Interleukin-8B | 1 | 2018 | 24 | 0.620 |
Why?
| | Pseudomonas | 1 | 2018 | 28 | 0.620 |
Why?
| | Klebsiella pneumoniae | 1 | 2018 | 42 | 0.610 |
Why?
| | Cells, Cultured | 8 | 2025 | 4077 | 0.580 |
Why?
| | Matrix Metalloproteinase 9 | 3 | 2022 | 119 | 0.560 |
Why?
| | Leukocytes | 1 | 2018 | 306 | 0.550 |
Why?
| | Epithelium | 3 | 2021 | 311 | 0.500 |
Why?
| | Drug Combinations | 3 | 2022 | 330 | 0.490 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 522 | 0.480 |
Why?
| | CD11b Antigen | 1 | 2015 | 60 | 0.470 |
Why?
| | Polypropylenes | 1 | 2013 | 14 | 0.430 |
Why?
| | 1-Methyl-3-isobutylxanthine | 2 | 2025 | 23 | 0.430 |
Why?
| | Colforsin | 2 | 2025 | 50 | 0.430 |
Why?
| | Serum Albumin, Bovine | 1 | 2013 | 63 | 0.420 |
Why?
| | Coated Materials, Biocompatible | 1 | 2013 | 59 | 0.410 |
Why?
| | Antibodies, Bacterial | 2 | 2010 | 137 | 0.400 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 833 | 0.390 |
Why?
| | Nasal Mucosa | 2 | 2024 | 107 | 0.380 |
Why?
| | Pneumococcal Infections | 2 | 2010 | 110 | 0.380 |
Why?
| | Monocytes | 1 | 2015 | 551 | 0.380 |
Why?
| | Aminopyridines | 3 | 2021 | 97 | 0.360 |
Why?
| | Biosynthetic Pathways | 1 | 2010 | 24 | 0.350 |
Why?
| | Serotyping | 4 | 2010 | 28 | 0.340 |
Why?
| | Bacteriological Techniques | 1 | 2010 | 69 | 0.330 |
Why?
| | Mutation | 6 | 2022 | 3710 | 0.330 |
Why?
| | Humans | 30 | 2025 | 129266 | 0.320 |
Why?
| | Exosomes | 2 | 2019 | 96 | 0.260 |
Why?
| | Immunity, Innate | 1 | 2012 | 803 | 0.260 |
Why?
| | Bronchi | 2 | 2019 | 247 | 0.250 |
Why?
| | Animals | 16 | 2025 | 35309 | 0.240 |
Why?
| | Thyroid Epithelial Cells | 1 | 2025 | 1 | 0.240 |
Why?
| | Thiazolidines | 1 | 2025 | 9 | 0.240 |
Why?
| | Benzoates | 1 | 2025 | 41 | 0.230 |
Why?
| | NIH 3T3 Cells | 2 | 2021 | 140 | 0.230 |
Why?
| | Ion Channel Gating | 1 | 2025 | 94 | 0.230 |
Why?
| | Rats, Inbred F344 | 1 | 2025 | 259 | 0.230 |
Why?
| | Genotype | 3 | 2021 | 1835 | 0.220 |
Why?
| | Proline | 2 | 2019 | 76 | 0.190 |
Why?
| | Mustard Gas | 1 | 2024 | 110 | 0.190 |
Why?
| | Dimethyl Sulfoxide | 1 | 2022 | 41 | 0.190 |
Why?
| | Chemical Warfare Agents | 1 | 2024 | 121 | 0.190 |
Why?
| | Respiratory System | 2 | 2022 | 154 | 0.180 |
Why?
| | Vaping | 1 | 2022 | 54 | 0.180 |
Why?
| | Electrophysiology | 1 | 2021 | 210 | 0.180 |
Why?
| | Rats | 3 | 2025 | 5482 | 0.180 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2835 | 0.180 |
Why?
| | Heterozygote | 1 | 2021 | 272 | 0.180 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 89 | 0.180 |
Why?
| | Ion Transport | 1 | 2020 | 62 | 0.170 |
Why?
| | Isocyanates | 1 | 2020 | 9 | 0.170 |
Why?
| | Forced Expiratory Volume | 2 | 2018 | 510 | 0.170 |
Why?
| | Drug Monitoring | 2 | 2018 | 216 | 0.170 |
Why?
| | Lipopolysaccharides | 3 | 2016 | 877 | 0.160 |
Why?
| | Respiratory Function Tests | 2 | 2018 | 583 | 0.160 |
Why?
| | Prodrugs | 1 | 2019 | 48 | 0.160 |
Why?
| | Sweat | 1 | 2018 | 46 | 0.150 |
Why?
| | Trachea | 1 | 2020 | 220 | 0.150 |
Why?
| | Down-Regulation | 1 | 2021 | 636 | 0.150 |
Why?
| | Biological Products | 1 | 2021 | 200 | 0.150 |
Why?
| | Airway Obstruction | 1 | 2020 | 152 | 0.150 |
Why?
| | Homozygote | 1 | 2018 | 193 | 0.150 |
Why?
| | Tissue Plasminogen Activator | 1 | 2020 | 222 | 0.150 |
Why?
| | Adult | 7 | 2020 | 35495 | 0.140 |
Why?
| | Temperature | 1 | 2021 | 634 | 0.140 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 307 | 0.140 |
Why?
| | Cilia | 1 | 2019 | 179 | 0.140 |
Why?
| | Mice | 6 | 2022 | 16915 | 0.140 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2017 | 25 | 0.140 |
Why?
| | ELAV-Like Protein 1 | 1 | 2017 | 16 | 0.140 |
Why?
| | Lung | 5 | 2024 | 3927 | 0.140 |
Why?
| | Gene Deletion | 1 | 2018 | 380 | 0.140 |
Why?
| | Sequence Analysis, DNA | 2 | 2010 | 776 | 0.140 |
Why?
| | Pseudomonas aeruginosa | 2 | 2016 | 347 | 0.140 |
Why?
| | Aztreonam | 1 | 2016 | 10 | 0.140 |
Why?
| | Male | 11 | 2022 | 63512 | 0.140 |
Why?
| | Inflammation | 4 | 2022 | 2737 | 0.140 |
Why?
| | Leukocyte Elastase | 2 | 2019 | 74 | 0.140 |
Why?
| | Doxycycline | 1 | 2017 | 59 | 0.130 |
Why?
| | Anti-Infective Agents | 1 | 2019 | 248 | 0.130 |
Why?
| | Tobramycin | 1 | 2016 | 51 | 0.130 |
Why?
| | Escherichia coli | 2 | 2012 | 766 | 0.130 |
Why?
| | Pulmonary Emphysema | 1 | 2019 | 275 | 0.130 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 219 | 0.130 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2017 | 68 | 0.130 |
Why?
| | Transcriptome | 1 | 2022 | 874 | 0.130 |
Why?
| | Azithromycin | 1 | 2016 | 93 | 0.130 |
Why?
| | Serine Endopeptidases | 1 | 2016 | 118 | 0.120 |
Why?
| | Microglia | 1 | 2017 | 232 | 0.120 |
Why?
| | Pseudomonas Infections | 1 | 2016 | 221 | 0.110 |
Why?
| | Statistics as Topic | 1 | 2015 | 307 | 0.110 |
Why?
| | Cell Line | 3 | 2017 | 2779 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2014 | 200 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2016 | 263 | 0.110 |
Why?
| | Medication Adherence | 1 | 2018 | 556 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2016 | 248 | 0.110 |
Why?
| | Logistic Models | 1 | 2018 | 1985 | 0.110 |
Why?
| | Adsorption | 1 | 2013 | 139 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1688 | 0.100 |
Why?
| | Reference Values | 1 | 2014 | 793 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1499 | 0.100 |
Why?
| | Genes, Bacterial | 2 | 2009 | 157 | 0.100 |
Why?
| | DNA, Bacterial | 2 | 2010 | 321 | 0.100 |
Why?
| | Proteolysis | 1 | 2012 | 167 | 0.090 |
Why?
| | Dinoprostone | 2 | 2022 | 187 | 0.090 |
Why?
| | Female | 8 | 2020 | 68551 | 0.090 |
Why?
| | Gene Order | 1 | 2010 | 26 | 0.090 |
Why?
| | Multilocus Sequence Typing | 1 | 2010 | 13 | 0.090 |
Why?
| | Cattle | 1 | 2013 | 977 | 0.090 |
Why?
| | Gene Transfer, Horizontal | 1 | 2010 | 29 | 0.090 |
Why?
| | Bacterial Typing Techniques | 1 | 2010 | 43 | 0.090 |
Why?
| | Phagocytosis | 1 | 2012 | 362 | 0.090 |
Why?
| | Cross Reactions | 1 | 2010 | 132 | 0.080 |
Why?
| | Matrix Metalloproteinases | 1 | 2011 | 90 | 0.080 |
Why?
| | Korea | 1 | 2009 | 10 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2010 | 332 | 0.080 |
Why?
| | Recombination, Genetic | 1 | 2010 | 190 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 389 | 0.080 |
Why?
| | Cluster Analysis | 1 | 2010 | 479 | 0.080 |
Why?
| | Genetic Loci | 1 | 2010 | 275 | 0.080 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2009 | 58 | 0.080 |
Why?
| | Oligopeptides | 2 | 2019 | 258 | 0.070 |
Why?
| | Escherichia coli Proteins | 1 | 2009 | 178 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2018 | 10202 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3080 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2146 | 0.070 |
Why?
| | Phylogeny | 1 | 2010 | 849 | 0.070 |
Why?
| | Evolution, Molecular | 1 | 2010 | 464 | 0.070 |
Why?
| | Sputum | 2 | 2019 | 301 | 0.060 |
Why?
| | Protein Binding | 1 | 2012 | 2120 | 0.060 |
Why?
| | Calcium | 1 | 2012 | 1212 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1155 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 1839 | 0.060 |
Why?
| | Mesna | 1 | 2024 | 15 | 0.060 |
Why?
| | Sodium | 1 | 2024 | 205 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1367 | 0.050 |
Why?
| | Angiotensins | 1 | 2022 | 9 | 0.050 |
Why?
| | Mesocricetus | 1 | 2022 | 37 | 0.050 |
Why?
| | Renin | 1 | 2022 | 32 | 0.050 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2022 | 54 | 0.050 |
Why?
| | Thromboplastin | 1 | 2022 | 70 | 0.050 |
Why?
| | Cricetinae | 1 | 2022 | 278 | 0.050 |
Why?
| | Lubiprostone | 1 | 2022 | 9 | 0.050 |
Why?
| | Antidotes | 1 | 2024 | 136 | 0.050 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2022 | 6 | 0.050 |
Why?
| | Cotinine | 1 | 2022 | 75 | 0.050 |
Why?
| | Prostaglandins | 1 | 2022 | 93 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2009 | 1446 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 147 | 0.050 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 983 | 0.050 |
Why?
| | Superoxide Dismutase | 1 | 2022 | 342 | 0.040 |
Why?
| | Cyanates | 1 | 2019 | 4 | 0.040 |
Why?
| | Nicotine | 1 | 2022 | 302 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 109 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 455 | 0.040 |
Why?
| | Selenium Compounds | 1 | 2019 | 21 | 0.040 |
Why?
| | Thiocyanates | 1 | 2019 | 31 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 520 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 530 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 138 | 0.040 |
Why?
| | Oscillometry | 1 | 2019 | 37 | 0.040 |
Why?
| | Chemotaxis | 1 | 2019 | 129 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4057 | 0.040 |
Why?
| | Smoke | 1 | 2019 | 139 | 0.040 |
Why?
| | Integrins | 1 | 2019 | 94 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 163 | 0.040 |
Why?
| | Anti-Bacterial Agents | 2 | 2019 | 1708 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 280 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 428 | 0.040 |
Why?
| | Microscopy | 1 | 2019 | 141 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 275 | 0.040 |
Why?
| | alpha 1-Antitrypsin | 1 | 2019 | 107 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5439 | 0.030 |
Why?
| | Matrix Metalloproteinase 12 | 1 | 2017 | 6 | 0.030 |
Why?
| | Alabama | 1 | 2017 | 33 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1202 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2016 | 38 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1247 | 0.030 |
Why?
| | Young Adult | 3 | 2017 | 12391 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 644 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 316 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 302 | 0.030 |
Why?
| | Signal Transduction | 2 | 2022 | 4926 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2016 | 272 | 0.030 |
Why?
| | Drug Interactions | 1 | 2016 | 393 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 10459 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 851 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2019 | 502 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 819 | 0.030 |
Why?
| | Spinal Cord | 1 | 2017 | 353 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2020 | 2396 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1487 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 450 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 915 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2017 | 1875 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1613 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2011 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2630 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 17 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 2011 | 60 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3074 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2011 | 61 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2011 | 107 | 0.020 |
Why?
| | Chromosomes, Bacterial | 1 | 2009 | 8 | 0.020 |
Why?
| | Origin Recognition Complex | 1 | 2009 | 3 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2703 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2009 | 44 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 65 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 2871 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3377 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 227 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2009 | 323 | 0.020 |
Why?
| | Brain | 1 | 2017 | 2669 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1716 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1710 | 0.010 |
Why?
| | Models, Biological | 1 | 2011 | 1722 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1484 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 20313 | 0.010 |
Why?
| | Aged | 1 | 2017 | 22032 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 31090 | 0.010 |
Why?
|
|
Bratcher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|